Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe BNP and NT-proBNP Market, by Location of Testing
1.4.2 Europe BNP and NT-proBNP Market, by Application
1.4.3 Europe BNP and NT-proBNP Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe BNP and NT-proBNP Market by Location of Testing
3.1 Europe Point of Care Testing Market by Country
3.2 Europe Laboratory Testing Market by Country
Chapter 4. Europe BNP and NT-proBNP Market by Application
4.1 Europe Myocardial Infarction Market by Country
4.2 Europe Acute Coronary Syndrome (ACS) Market by Country
4.3 Europe Congestive Heart Failure (CHF) Market by Country
4.4 Europe Others Market by Country
Chapter 5. Europe BNP and NT-proBNP Market by Country
5.1 Germany BNP and NT-proBNP Market
5.1.1 Germany BNP and NT-proBNP Market by Location of Testing
5.1.2 Germany BNP and NT-proBNP Market by Application
5.2 UK BNP and NT-proBNP Market
5.2.1 UK BNP and NT-proBNP Market by Location of Testing
5.2.2 UK BNP and NT-proBNP Market by Application
5.3 France BNP and NT-proBNP Market
5.3.1 France BNP and NT-proBNP Market by Location of Testing
5.3.2 France BNP and NT-proBNP Market by Application
5.4 Russia BNP and NT-proBNP Market
5.4.1 Russia BNP and NT-proBNP Market by Location of Testing
5.4.2 Russia BNP and NT-proBNP Market by Application
5.5 Spain BNP and NT-proBNP Market
5.5.1 Spain BNP and NT-proBNP Market by Location of Testing
5.5.2 Spain BNP and NT-proBNP Market by Application
5.6 Italy BNP and NT-proBNP Market
5.6.1 Italy BNP and NT-proBNP Market by Location of Testing
5.6.2 Italy BNP and NT-proBNP Market by Application
5.7 Rest of Europe BNP and NT-proBNP Market
5.7.1 Rest of Europe BNP and NT-proBNP Market by Location of Testing
5.7.2 Rest of Europe BNP and NT-proBNP Market by Application
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 Siemens AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 SWOT Analysis
6.3 Danaher Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Gentian Diagnostics ASA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 PerkinElmer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 BioMérieux S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Quidel Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Bio-Rad laboratories, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.10. Scripps Laboratories
6.10.1 Company Overview
Unique Offerings 
